Final answer:
Intracranial hemorrhage is a contraindication for the administration of tissue plasminogen activator (t-PA), a thrombolytic agent used in the treatment of thrombotic strokes.
Step-by-step explanation:
One of the contraindications for the administration of tissue plasminogen activator (t-PA), a thrombolytic agent used to treat thrombotic strokes, is the presence of an intracranial hemorrhage. While t-PA can significantly improve the prognosis of patients who have suffered a thrombotic stroke when administered within 3 hours of the stroke onset, its use is not safe if the stroke is hemorrhagic in nature, as t-PA can exacerbate bleeding. The correct choice in this case is option (a) Intracranial hemorrhage.